Human T-lymphotropic virus type I/II infections in volunteer blood donors from Northern and Western Greece: Increased prevalence in one blood bank unit

European Journal of Internal Medicine

Volumn 15, Issue 7, 2004, Pages 422-427

  Zervou, E K ^a   Georgiadou, S ^b   Tzilianos, M ^c   Georgitsi, P ^a   Pournara, V ^d   Nousis, S ^e   Pappas, C ^f   Daskalou, L ^g   Vrettou, A ^h   Karabini, F ^a   Dalekos, G N ^b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c Blood Bank the Gen Hosp of Corfu   (Greece)

^d Blood Bank Gen Hosp of Agrinion   (Greece)

^e Greece   (Greece)

^f Blood Bank at the Gen Hosp of Arta   (Greece)

^g General Hospital of Preveza   (Greece)

^h Blood Bank the Gen Hosp of Lefkada   (Greece)

Author keywords

Blood donation; HTLV DNA; Human T cell lymphotropic virus (HTLV); Western blot

Indexed keywords

BIOCHEMICAL MARKER; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; CONFIDENCE INTERVAL; ENZYME IMMUNOASSAY; FEMALE; GREECE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VOLUNTEER; WESTERN BLOTTING;

EID: 9744281918     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.06.009     Document Type: Article

References (36)

1. V. Zaninovic On the etiology of tropical spastic paraparesis and human T-cell lymphotropic virus-I-associated myelopathy Int. J. Infect. Dis. 3 1999 168 176
2. K. Nishioka HTLV-I arthropathy and Sjogren syndrome J. Acquir. Immune Defic. Syndr. Human Retrovirol. 13 Suppl. 1 1996 S57 S62
3. Y. Furukawa, R. Kubota, N. Eiraku, M. Nakagawa, K. Usuku, and S. Izumo Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings for HTLV-I-infected blood donors J. Acquir. Immune Defic. Syndr. 32 2003 328 334
4. W.W. Hall, R. Ishak, S.W. Zhu, P. Novoa, N. Eiraku, and H. Takahashi Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection J. Acquir. Immune Defic. Syndr. Human Retrovirol. 13 Suppl. 1 1996 S204 S214
5. T. Takezaki, K. Tajima, M. Ito, S. Ito, K. Kinoshita, and K. Tachibana Short term breast-feeding may reduce the risk of vertical transmission of HTLV-I Leukemia 11 1997 60 62 (Suppl.)
6. O.G. Ferreira Jr., J.D. Planalles, and J.D. Rosenblatt Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis Blood Rev. 11 1997 91 104
7. M. Giuliani, G. Rezza, A.C. Lepri, A. Di Carlo, A. Maini, and E. Crescimbini Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases Sex Transm. Dis. 27 2000 87 92
8. R.F. Edlich, J.A. Arnette, and F.M. Williams Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I) J. Emerg. Med. 18 2000 109 119
9. A. Manns, M. Hisada, and L. La Grenade Human T-lymphotropic virus type I infection Lancet 353 1999 1951 1959
10. W.G. Lowis, W.A. Sheremata, and A. Minagar Epidemiologic features of HTLV-II: serologic and molecular evidence Ann. Epidemiol. 12 2002 46 66
11. G.N. Dalekos, E. Zervou, F. Karabini, M. Elisaf, K. Bourantas, and K.C. Siamopoulos Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece Transfusion 35 1995 503 506
12. E.K. Zervou, D.S. Boumba, Ch. Liaskos, S. Georgiadou, E.V. Tsianos, and G.N. Dalekos Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997) Eur. J. Intern. Med. 14 2003 39 44
13. E.K. Zervou, G.N. Dalekos, D.S. Boumba, and E.V. Tsianos Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece Transfusion 41 2001 652 658
14. A. Roumeliotou-Karayannis, N. Tassopoulos, M. Kotsianopoulou, E. Karpodini, E. Trichopoulou, and G. Papaevangelou Prevalence of HBV, HDV and LAV/HTLV infections among Greek drug addicts Prog. Clin. Biol. Res. 234 1987 403 404
15. K. Yamaguchi Human T-lymphotropic virus type I in Japan Lancet 343 1994 213 216
16. A.E. Williams, C.T. Fang, D.J. Slamon, B.J. Poiesz, S.G. Sandler, and W.F. Darr II Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors Science 240 1988 643 646
17. H.H. Lee, P. Swanson, J.D. Rosenblatt, I.S. Chen, W.C. Sherwood, and D.E. Smith Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors Lancet 337 1991 1435 1439
18. R.Y. Dodd, E.P. Notary, and S.L. Stramer Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population Transfusion 42 2002 975 979
19. A.M. Courouce, J. Pillonel, J.M. Lemaire, and C. Saura HTLV testing in blood transfusion Vox Sang. 74 Suppl. 2 1998 165 169
20. G.P. Taylor The epidemiology and clinical impact of HTLV infections in Europe AIDS Rev. 1 1999 195 204
21. J. Boni, L.R. Bisset, J.J. Burckhardt, H.I. Joller-Jemelka, P. Burgisser, and L. Perrin Prevalence of human T-cell Leukemia virus types I and II in Switzerland J. Med. Virol. 72 2004 328 337
22. F.J. Medrano, V. Soriano, E.J. Calderon, C. Rey, M. Gutierrez, and R. Bravo Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk Eur. J. Clin. Microbiol. Infect. Dis. 16 1997 249 252
23. H. Liu, M. Shah, S.L. Stramer, W. Chen, B.J. Weiblen, and E.L. Murphy Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II Transfusion 39 1999 1185 1193
24. G.B. Schreiber, E.L. Murphy, J.A. Horton, D.J. Wright, R. Garfein, H.C. Chien NHLBI Retrovirus Epidemiology Donor Study Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study J. Acquir. Immune Defic. Syndr. Human Retrovirol. 14 1997 263 271
25. V. Soriano, A. Vallejo, M. Gutierrez, C. Tuset, G. Cilla, R. Martinez-Zapico HTLV Spanish Study Group Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain Eur. J. Epidemiol. 12 1996 625 629
26. M.P. Busch, M. Laycock, S.H. Kleinman, J.W. Wages Jr., M. Calabro, J.E. Kaplan Retrovirus Epidemiology Donor Study (REDS) Accuracy of supplementary serological testing for human T-lymphotropic virus (HTLV) types I and II in US blood donors Blood 83 1994 1143 1148
27. Centers for Disease Control and Prevention and the USPHS Working Group Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II) Ann. Intern. Med. 118 1993 448 454
28. S. Dube, S. Bachman, T. Spicer, J. Love, D. Choi, and E. Esteban Degenerate and specific PCR assays for the detection of bovine leukemia/lymphoma virus polDNA and RNA phylogenetic comparisons of amplified sequences from cattle and primates from around the world J. Gen. Virol. 78 1997 1389 1398
29. M.P. Busch, W.M. Switzer, E.L. Murphy, R. Thomson, and W. Heneine Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results Transfusion 40 2000 443 449
30. International Agency for research on Cancer. Human immunodeficiency viruses and human T-cell lymphotropic viruses. LYONS: IARC, 1996. (Monographs on the evaluation of Carcinogenic Risk to Humans, Vol. 67).
31. J. Tosswill, G.P Taylor, R.S. Tedder, and P.P. Mortimer HTLV I-II associated disease in England and Wales, 1993-7: retrospective review of serology requests BMJ 320 2000 611 612
32. W.A. Blattner Human T-lymphotropic viruses and diseases of long latency Ann. Intern. Med. 111 1989 4 6
33. H.E. Ownby, J.J. Korelitz, M.P. Busch, A.E. Williams, S.H. Kleinman, R.O. Gilcher Retrovirus Epidemiology Donor Study Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results Transfusion 37 1997 199 205
34. J.N. Weber, and G.P. Taylor Antenatal screening is important BMJ 312 1996 312 702
35. M. Donati, H. Seyedzadeh, T. Leung, M. Blitt, and M. Zuckerman Prevalence of antibody to human T cell leukemia/lymphoma virus in women attending antenatal clinic in southeast London: retrospective study BMJ 320 2000 92 93
36. A.E. Ades, S. Parker, J. Walker, M. Edginton, G.P. Taylor, and J.N. Weber Human T cell leukemia/lymphoma virus infection in pregnant women in the United Kingdom: a population study BMJ 320 2000 1497 1501